Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



This Is the 1 Health-Care Story You Can't Afford to Miss This Week

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Each week I attempt to point out five newsworthy stories in the health-care sector that you as investors should keep your eyes on in the week ahead. With the week ahead being shortened by one of my favorite holidays, Thanksgiving, news events across all sectors, including health-care, are slim pickings at best. There are no FDA panel meetings scheduled, no major health-care conferences, and just five companies in total reporting earnings in the sector. Of those five, there's just one report worth keeping your eye on – but it's a mammoth one!

Medical-device giant Medtronic (NYSE: MDT  ) is slated to report its second-quarter earnings results on Tuesday, with analysts expecting the company to earn $0.88 per share on a 2% decline in revenue to $4.05 billion from the year-ago quarter.

We've already been given some decent clues of what to expect from Medtronic's peers, although the results have been generally mixed because of challenging global sales environments. In the positive column, St. Jude Medical (NYSE: STJ  ) surpassed Wall Street's third-quarter expectations by $0.02 as restructuring charges weighed on its profits. Johnson & Johnson (NYSE: JNJ  ) , which recently completed its purchase of Synthes to add to its growing portfolio of medical devices, reported a quarterly profit of $1.25, $0.04 better than expectations, despite the impact of negative currency translation.

Conversely, Baxter International (NYSE: BAX  ) reduced its top-line earnings forecast last month and slightly missed sales estimates, which, too, were hurt by foreign currency translation. Luckily for Baxter, its management thinks its focus on unmet medical needs will shield it from macroeconomic weakness. Boston Scientific (NYSE: BSX  ) wasn't as lucky, reporting a one-time loss-filled third-quarter in which sales fell more than 7%.  

The lesson from these reports is that European spending is a mess. More exposure to Europe has meant more possibility of a revenue shortfall. Therefore, it wouldn't be a shock to see Medtronic come in a tad light on second-quarter revenue.

It's also worth keeping an eye on whether Medtronic plans to expand or cut back its operations as we head into 2013. If you recall, the passing of the Affordable Care Act is going to begin levying a 2.3% medical-device excise tax on companies like Medtronic beginning in 2013 to help pay for the expansion of the Medicaid program. We've already seen device companies laying off workers, either directly or indirectly related to the ACA, and/or moving their operations overseas. Boston Scientific has been actively investing in China, and St. Jude recently outlined plans to increase its round of layoffs by an additional 500 people. In short, device companies are looking to continue growing, but are reducing their costs and operations within the United States. It should be interesting to see what the largest medical-device maker has to say regarding the implementation of the ACA.

Does Medtronic have what it takes?
We'll find out on Tuesday if Medtronic has what it takes to be considered a long-term champion. In the meantime, I encourage you to check out our latest special report on three companies that do have all of the tools necessary to help you retire rich. Click here to learn more and find out the identity of these three handpicked stocks, for free!

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2118337, ~/Articles/ArticleHandler.aspx, 10/22/2016 5:13:13 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 7 hours ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 4:00 PM
MDT $83.91 Down -0.11 -0.13%
Medtronic CAPS Rating: *****
BAX $48.18 Down -0.01 -0.02%
Baxter CAPS Rating: ****
BSX $22.82 Down -0.19 -0.83%
Boston Scientific CAPS Rating: ***
JNJ $113.44 Down -1.43 -1.24%
Johnson and Johnso… CAPS Rating: ****
STJ $79.36 Down -0.27 -0.34%
St. Jude Medical CAPS Rating: **